Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2023-04-03 AGM Information
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 99% confidence The document is explicitly titled 'NOTICE OF ORDINARY GENERAL MEETING' and details the agenda for a meeting scheduled for April 24th, 2023. The agenda items cover the approval of the annual report, profit distribution, election of board members, and changes to articles of association. Furthermore, the document includes an attachment section listing 'Form of proxy' and 'Medistim ASA POWER OF ATTORNEY ORDINARY GENERAL MEETING 24 APRIL 2023'. This content is characteristic of materials distributed to shareholders in advance of an Annual General Meeting (AGM) to inform them of the proceedings and solicit proxy votes. Therefore, the appropriate classification is AGM-R (AGM Information).
2023-04-03 English
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 98% confidence The document explicitly announces the 'Notice of Annual General Meeting in Medistim ASA' and provides the date, time, and location for the meeting. It also mentions that the agenda, voting form, and the annual report for 2022 are attached. Since the primary purpose is to notify shareholders about the AGM and solicit participation/voting, the most appropriate classification is AGM Information (AGM-R). Although it mentions the annual report is attached, the document itself is the notice for the meeting, not the full report or a general announcement of report publication.
2023-04-03 English
Medistim is opening a direct sales office in China
Regulatory Filings Classification · 100% confidence The document is a press release dated April 3, 2023, announcing that Medistim ASA is opening a direct sales office in China (Guangzhou). It details strategic expansion, market opportunities, and changes in distribution partnerships. This type of announcement, which concerns operational strategy and market presence rather than formal financial reporting (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA), fits best under the general category for regulatory announcements or news releases that don't have a more specific code. Since it is not a formal financial report, a management discussion, or a specific corporate action filing, it falls under the general Regulatory Filings (RNS) category, which serves as a broad category for official company news releases.
2023-04-03 English
Annual report for 2022 for Medistim ASA
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2022' and contains comprehensive sections typical of a full annual report, including a letter from the CEO, board of directors' report, corporate governance report, sustainability report, and full consolidated financial statements for the group and parent company. It is clearly the primary annual financial and operational disclosure for the company for the 2022 fiscal year. FY 2022
2023-03-30 English
Annual report for 2022 for Medistim ASA
Annual Report Classification · 100% confidence The document is titled 'MEDISTIM ANNUAL REPORT - FISCAL YEAR 2022' and contains detailed sections typical of an annual report, including a letter from the CEO, executive management and board of directors information, operational and financial reviews, corporate governance report, sustainability report, consolidated and parent company financial statements, accounting principles, notes to the accounts, alternative performance measures, responsibility statement, and auditor's report. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content covers comprehensive company activity and full financial performance for the fiscal year 2022, consistent with an official yearly report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-03-30 English
Annual report for 2022 for Medistim ASA
Report Publication Announcement Classification · 100% confidence The document explicitly states: 'Annual report for 2022 for Medistim ASA' and 'announces that the Annual Report for 2022 is approved and available.' However, the document length is very short (1259 characters) and it functions primarily as an announcement that the full report is ready, rather than containing the full financial statements or management discussion characteristic of a full 10-K or IR filing. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report is available points towards a Report Publication Announcement (RPA). Although the subject is the Annual Report, the document's function here is to announce its publication.
2023-03-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.